Product Information
TRANEXAMIC ACID 1,000 MG/10 ML is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.4035 per ML under NDC 23155091041. Its NADAC has been published 78 times since Apr 9, 2025.
FDA first approved this application on Feb 11, 2014. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/mL
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155091041
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
TRANEXAMIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA202436FDA Approved
2/11/2014
TE Code
AP
On Market Since
11/25/2024
Pharmacological Classes
Price Statistics
The NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has been published 78 times since Apr 9, 2025, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4035 per ML |
|---|---|
| All-time high | $0.4035 (Sep 30, 2026) |
| All-time low | $0.3481 (Apr 9, 2025) |
| 52-week high | $0.4035 |
| 52-week low | $0.3481 |
| Median price | $0.3481 |
| Average price | $0.3555 |
| Largest weekly change | +5.1% (Jul 22, 2026) |
| Weeks tracked | 78 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tranexamic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antifibrinolytic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRANEXAMIC ACID 1,000 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TRANEXAMIC ACID 1,000 MG/10 ML, manufactured by Heritage Pharmaceuticals Inc., is $0.4035 per ML (NDC 23155091041), effective Sep 30, 2026.
How has the price of TRANEXAMIC ACID 1,000 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has risen 15.9%. It has been tracked across 78 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for TRANEXAMIC ACID 1,000 MG/10 ML?
Since Apr 9, 2025, the NADAC for TRANEXAMIC ACID 1,000 MG/10 ML has ranged from a low of $0.3481 (Apr 9, 2025) to a high of $0.4035 (Sep 30, 2026), with a median of $0.3481 per ML.
Are there cheaper alternatives to TRANEXAMIC ACID 1,000 MG/10 ML?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRANEXAMIC ACID 1,000 MG/10 ML, is $0.3481 per ML — about 14% below TRANEXAMIC ACID 1,000 MG/10 ML.
Who manufactures TRANEXAMIC ACID 1,000 MG/10 ML?
TRANEXAMIC ACID 1,000 MG/10 ML (NDC 23155091041) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.